Comparison of home occult blood tests and interaction of tests with ibuprofen.
The interaction of ibuprofen with home tests for occult blood was evaluated, and the accuracy of these tests was determined by validating the results with a specific quantitative assay of stool blood. Three home occult blood tests were evaluated: Early Detector, Fleet Detecatest, and CS-T Coloscreen Self Test. Fourteen men 19 to 35 years of age were instructed on how to use the tests and to record each day their dietary intake and stool consistency, the color of test control areas, the results, and the times of ibuprofen administration. The study consisted of a control period (days 0-5) and short-term (days 6-9) and long-term (days 10-14) ibuprofen periods. Each subject took two 200-mg tablets of ibuprofen three times daily beginning on day 6 and ending on day 14. During each study period, one stool sample was collected on each of three consecutive days. All three tests were performed on each sample, in addition to specific quantitative analysis with HemoQuant. All samples in the control period were negative for occult blood. Three positive results were reported by subject 4 in the short-term ibuprofen period, one with Fleet Detecatest and two with Early Detector. Subject 6 reported two positive Fleet Detecatest results and three positive Early Detector results during the long-term drug period. No positive results were detected with CS-T Coloscreen Self Test. The HemoQuant values showed that Early Detector produced one false-negative and two false-positive results.(ABSTRACT TRUNCATED AT 250 WORDS)
Collins
C L
CL
University of Michigan College of Pharmacy, Ann Arbor 48109.
DeTullio
P L
PL
Berardi
R R
RR
Elta
G H
GH
Patterson
R W
RW
D000328:Adult; D015179:Colorectal Neoplasms / Q000175:diagnosis*; D005189:False Positive Reactions; D006801:Humans; D007052:Ibuprofen / Q000009:adverse effects*; D008297:Male; D009780:Occult Blood
D007052:Ibuprofen